301.869.9683 | customersupport@opgen.com
OpGen
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Clinical Advisory Board
    • Careers
  • Surveillance
    • Overview
    • Demonstrated Results
    • High Risk Patients
    • Send Specimens
    • Acuitas Lighthouse®
      • Lighthouse Profile
    • Acuitas Tests
    • Publications
    • Client Services Info Request
  • Sequencing
    • Overview
    • Transmission Investigation
    • Resistance Genotyping
    • Custom Services
  • Pathogen ID
    • Overview
    • QuickFISH® Products
      • Staphylococcus QuickFISH®
      • Enterococcus QuickFISH®
      • Gram-Negative QuickFISH®
      • Candida QuickFISH®
    • PNA FISH® Products
      • S. aureus/CNS PNA FISH®
      • E. faecalis/OE PNA FISH®
      • Gram-Negative PNA FISH®
      • Candida PNA FISH®
    • Accessories
    • Clinical Benefits Studies
    • Image Gallery
    • SDS
    • Distributors
  • Investors
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • SEC Filings
    • Investor FAQs
    • Corporate Governance
    • Financial Information
      • Annual Reports
      • Quarterly Information
    • Shareholder Services
      • IR Contacts
      • Information Request
      • Email Alerts
  • Contact Us

Acuitas Tests

Identify presence of antibiotic resistance quickly and with high sensitivity and specificity.

Make better informed infection control decisions.

Detects genes associated with CRE, Carbapenemase Producers, CTX-M related ESBLs, and VRE directly from one swab*.

  • Coverage of more than 200 sub-types.
  • Results delivered from OpGen’s laboratory services.

*Validated for peri-anal swabs collected with Eswabs™ (trademark of Copan Diagnostics, Inc). Culture isolates also validated.

 

Quickly screen for antibiotic resistance genes and confirm the presence of CRE

From one surveillance swab*, test specimens with the Acuitas MDRO Gene Test and phenotypic methods to confirm presence of Carbapenem Resistant Enterobacteriaceae (CRE).

  • Highly sensitive carbapenemase gene detection.
  • Isolate obtained from CRE Selective Culture.
  • ID/AST confirms organism identity and antibiotic susceptibility profile.
  • Results delivered from OpGen’s laboratory services.

*Validated for peri-anal swabs collected with Eswabs™. Culture isolates also validated.

 

Rapid and comprehensive genotyping of MDRO isolates

Characterize isolates by genes of resistance to determine strain relatedness in days.

Acuitas Resistome Test

  • Creates Molecular Profile – Resistome results are used to create objective , gene-based “digital” profiles in the Acuitas Lighthouse MDRO Management System.
  • Comprehensive – Detects 46 genes associated with major drug resistance classes: Carbapenemases (including plasmid mediated CRE genes), ESBL, & AmpCs.
  • Accurate – 99% concordance to resistance gene detection with Whole Genome Sequencing (WGS).
  • Informative – quickly determines differences among isolates and selects candidates for higher resolution Acuitas Whole Genome Sequence Analysis.
  • Analysis available from culture isolates.

Coverage of 46 resistance genes and over 900 subtypes of CRE, ESBL and AmpCs

 

Comprehensive gene menu
protects patients and
aids clinical decisions.

 

For Research Use Only. Not for use in diagnostic procedures.

Surveillance

  • Overview
  • Demonstrated Results
  • High Risk Patients
  • Send Specimens
  • Acuitas Lighthouse®
    • Lighthouse Profile
  • Acuitas Tests
  • Publications
  • Client Services Info Request

Copyright © 2019 OpGen. All rights reserved.

  • Twitter
  • LinkedIn
  • FaceBook
  • YouTube

Sitemap | Terms of Use | Privacy | Contact

Website Design & Development by Graphic Beans